Delair Bolis, Head of the Global Poultry Unit with MSD Animal Health, shares industry trends with ThePoultrySite's Sarah Mikesell at IPPE in Atlanta in early February.

First, the big question is how the poultry industry will react to the ongoing global Avian Influenza outbreaks.

"In the last 60 days, we have had more than 33 or 34 countries already confirm outbreaks," said Delair Bolis, Head of the Global Poultry Unit with MSD Animal Health. "We as a company are here once again to provide the best solutions that we can, not only product-oriented but also strategically through our Step Up to Solutions program, offering consultants to address customers' unmet needs specifically regarding the outbreaks that the industry is facing."

The second trend is antibiotic free (ABF) production, which started in 2015 and is gaining momentum. It's taken hold in the US market and is spreading around the world.

"In order to help our customers with ABF production, we're launching a new coccidiosis vaccine, Coccivac-B52," he said. "We've launched it in the US and now are expanding to countries in Latin America and Asian Pacific."

The third trend is innovation. Year-after-year, innovation has always been part of the foundation of the poultry industry, he said. To address the need for innovation, MSD will launch two new Innovax franchise vaccines in 2017.

"We'll be there for the poultry industry supporting all the needs, but even more important, we'll be addressing the unmet needs," said Bolis. "Our main goal is helping the poultry industry become more profitable and gain market access."